This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1986 Jul;22(1):121-2.

Metabolite residence time: influence of the first-pass effect

M Weiss

PMID: 3741722
PMCID: PMC1401090

Metabolite residence time: influence of the first-pass effect

M Weiss. Br J Clin Pharmacol. 1986 Jul.

. 1986 Jul;22(1):121-2.

Author

M Weiss

PMID: 3741722
PMCID: PMC1401090

No abstract available

PubMed Disclaimer

Similar articles

Oral bioavailability and first-pass effects.
Kwan KC. Kwan KC. Drug Metab Dispos. 1997 Dec;25(12):1329-36. Drug Metab Dispos. 1997. PMID: 9394021 Review.
[Apparatus for the in vitro study of drug absorption].
Bastide R, Rouffiac R, Stanislas E. Bastide R, et al. Pharm Acta Helv. 1972 May;47(5):295-303. Pharm Acta Helv. 1972. PMID: 5045746 French. No abstract available.
Effects of first-pass metabolism on metabolite mean residence time determination after oral administration of parent drug.
Chan KK, Gibaldi M. Chan KK, et al. Pharm Res. 1990 Jan;7(1):59-63. doi: 10.1023/a:1015887626171. Pharm Res. 1990. PMID: 2300537
Metabolite pharmacokinetics: methods for simultaneous estimates of elimination rate constants of a drug and its metabolite. A commentary.
Pang KS, Gillette JR. Pang KS, et al. Drug Metab Dispos. 1980 Jan-Feb;8(1):39-43. Drug Metab Dispos. 1980. PMID: 6102028 No abstract available.
Mean residence time of oral drugs undergoing first-pass and linear reversible metabolism.
Cheng H, Jusko WJ. Cheng H, et al. Pharm Res. 1993 Jan;10(1):8-13. doi: 10.1023/a:1018904509178. Pharm Res. 1993. PMID: 8430064 Review.

See all similar articles

Cited by

Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).
Veng-Pedersen P. Veng-Pedersen P. Clin Pharmacokinet. 1989 Dec;17(6):424-40. doi: 10.2165/00003088-198917060-00005. Clin Pharmacokinet. 1989. PMID: 2689041 Review.
Primary, secondary, and tertiary metabolite kinetics.
St-Pierre MV, Xu X, Pang KS. St-Pierre MV, et al. J Pharmacokinet Biopharm. 1988 Oct;16(5):493-527. doi: 10.1007/BF01062382. J Pharmacokinet Biopharm. 1988. PMID: 3199316
The relevance of residence time theory to pharmacokinetics.
Weiss M. Weiss M. Eur J Clin Pharmacol. 1992;43(6):571-9. doi: 10.1007/BF02284953. Eur J Clin Pharmacol. 1992. PMID: 1493836 No abstract available.
Use of metabolite AUC data in bioavailability studies to discriminate between absorption and first-pass extraction.
Weiss M. Weiss M. Clin Pharmacokinet. 1990 May;18(5):419-22. doi: 10.2165/00003088-199018050-00006. Clin Pharmacokinet. 1990. PMID: 2335047 No abstract available.

References

1. Br J Clin Pharmacol. 1985 Jun;19(6):855-6 - PubMed
1. Eur J Clin Pharmacol. 1985;29(1):45-8 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information